- Home
- DYN vs BUSE Comparison
DYN vs BUSE Comparison
Compare DYN & BUSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DYN | BUSE |
|---|---|---|
| Founded | 1984 | 1868 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | DYN | BUSE |
|---|---|---|
| Price | $15.26 | $25.69 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 6 |
| Target Price | ★ $38.63 | $27.00 |
| AVG Volume (30 Days) | ★ 1.6M | 566.3K |
| Earning Date | 06-03-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 4.03% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.47 |
| Revenue | N/A | ★ $719,584,000.00 |
| Revenue This Year | N/A | $23.61 |
| Revenue Next Year | N/A | $3.69 |
| P/E Ratio | ★ N/A | $17.59 |
| Revenue Growth | N/A | ★ 55.66 |
| 52 Week Low | $7.01 | $18.40 |
| 52 Week High | $25.00 | $27.65 |
Technical Indicators
Market Signals| Indicator | DYN | BUSE |
|---|---|---|
| Relative Strength Index (RSI) | 42.46 | 49.46 |
| Support Level | $14.67 | $23.53 |
| Resistance Level | $19.65 | $26.08 |
| Average True Range (ATR) | 0.95 | 0.75 |
| MACD | 0.02 | -0.14 |
| Stochastic Oscillator | 46.49 | 41.44 |
Price Performance
Historical ComparisonAbout DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About BUSE First Busey Corporation
First Busey Corporation is a financial holding company, whose subsidiaries provides retail and commercial banking services, remittance processing, and offers financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech and Wealth Management. The banking segment generates a vast majority of its revenue.